BB BIOTECH AG
BB BIOTECH AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB BIOTECH AG invests mainly in companies operating in such sectors as oncology, cardiovascular diseases, infectious diseases and autoimmune diseases. As of December 31, 2009, the Company’s portfolio comprised 23 companies, including Actelion, Gilead, Celgene, Genentech, Biogen Idec, Vertex Pharmaceuticals, Elan, Basilea Pharmaceuticals and Roche Holding GS, among others. The investments are held through its wholly owned subsidiaries, which include Biotech Focus NV, Biotech Invest NV, Biotech Target NV and Biotech Growth NV.
Contact Details
Executives
Chairman
Prof Thomas D. Szucs
Media Relations
Thomas Egger